SK281432B6 - Spôsob prípravy n-acetyl-(l)-4-kyanofenylalanínu ac-(l)-phe(4- -cn)-oh a n-acetyl-(l)-p-amidinofenylalanín-cyklohexylglycín- -beta-(3-n-metylpyridínium)-alanínu ac-(l)-paph-chg-palme(3)-nh2 - Google Patents

Spôsob prípravy n-acetyl-(l)-4-kyanofenylalanínu ac-(l)-phe(4- -cn)-oh a n-acetyl-(l)-p-amidinofenylalanín-cyklohexylglycín- -beta-(3-n-metylpyridínium)-alanínu ac-(l)-paph-chg-palme(3)-nh2 Download PDF

Info

Publication number
SK281432B6
SK281432B6 SK855-98A SK85598A SK281432B6 SK 281432 B6 SK281432 B6 SK 281432B6 SK 85598 A SK85598 A SK 85598A SK 281432 B6 SK281432 B6 SK 281432B6
Authority
SK
Slovakia
Prior art keywords
compound
formula
reaction medium
sufficient amount
amount
Prior art date
Application number
SK855-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK85598A3 (en
Inventor
Chi-Hsin R. King
Original Assignee
Hoechst Marion Roussel, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel, Inc. filed Critical Hoechst Marion Roussel, Inc.
Publication of SK85598A3 publication Critical patent/SK85598A3/sk
Publication of SK281432B6 publication Critical patent/SK281432B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SK855-98A 1995-12-20 1996-11-25 Spôsob prípravy n-acetyl-(l)-4-kyanofenylalanínu ac-(l)-phe(4- -cn)-oh a n-acetyl-(l)-p-amidinofenylalanín-cyklohexylglycín- -beta-(3-n-metylpyridínium)-alanínu ac-(l)-paph-chg-palme(3)-nh2 SK281432B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57556995A 1995-12-20 1995-12-20
PCT/US1996/019005 WO1997022712A1 (en) 1995-12-20 1996-11-25 NOVEL PROCESS FOR PREPARING N-ACETYL(L)-4-CYANOPHENYLALANINE Ac-(L)-Phe(4-CN)-OH AND N-ACETYL-(L)-p-AMIDINOPHENYLALANINE-CYCLOHEXYLGLYCINE-β-(3-N-METHYLPYRIDINIUM)-ALANINE Ac-(L)-pAph-Chg-PalMe(3)-NH¿2?

Publications (2)

Publication Number Publication Date
SK85598A3 SK85598A3 (en) 1998-12-02
SK281432B6 true SK281432B6 (sk) 2001-03-12

Family

ID=24300839

Family Applications (1)

Application Number Title Priority Date Filing Date
SK855-98A SK281432B6 (sk) 1995-12-20 1996-11-25 Spôsob prípravy n-acetyl-(l)-4-kyanofenylalanínu ac-(l)-phe(4- -cn)-oh a n-acetyl-(l)-p-amidinofenylalanín-cyklohexylglycín- -beta-(3-n-metylpyridínium)-alanínu ac-(l)-paph-chg-palme(3)-nh2

Country Status (27)

Country Link
EP (1) EP0868526B1 (pt)
JP (1) JP4044614B2 (pt)
KR (1) KR100438879B1 (pt)
CN (1) CN1087349C (pt)
AR (1) AR005119A1 (pt)
AT (1) ATE222293T1 (pt)
AU (1) AU717995B2 (pt)
BR (1) BR9612059A (pt)
CA (1) CA2241210C (pt)
CZ (1) CZ295362B6 (pt)
DE (1) DE69623038T2 (pt)
DK (1) DK0868526T3 (pt)
EE (1) EE03698B1 (pt)
ES (1) ES2179957T3 (pt)
HK (1) HK1017384A1 (pt)
IL (1) IL125003A (pt)
MX (1) MX9804997A (pt)
NO (1) NO319678B1 (pt)
NZ (1) NZ324159A (pt)
PL (1) PL185541B1 (pt)
PT (1) PT868526E (pt)
RU (1) RU2170764C2 (pt)
SK (1) SK281432B6 (pt)
TR (1) TR199801107T2 (pt)
UA (1) UA48993C2 (pt)
WO (1) WO1997022712A1 (pt)
ZA (1) ZA9610600B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1016663A1 (en) * 1999-01-02 2000-07-05 Aventis Pharma Deutschland GmbH Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor Xa activity)
TR200101903T2 (tr) * 1999-01-02 2001-11-21 Aventis Pharma Deutschland Gmbh Yeni malonik asit türevleri, bunların preparasyon işlemleri.
MXPA02006762A (es) * 2000-01-28 2002-10-23 Aventis Pharma Gmbh Proceso para la preparacion de acetil-amidinoifenilalanil -ciclohexilglicil -piridinoalaninamidas.
EP1127884A1 (en) 2000-02-26 2001-08-29 Aventis Pharma Deutschland GmbH Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them
PT1569912E (pt) 2002-12-03 2015-09-15 Pharmacyclics Llc Derivados 2-(2-hidroxibifenil-3-il)-1h-benzoimidazole-5- carboxamidina como inibidores do fator viia
GB0306267D0 (en) 2003-03-19 2003-04-23 Ineos Fluor Ltd Process
JP2008260755A (ja) * 2007-03-20 2008-10-30 Sumitomo Chemical Co Ltd Ｌ−ビフェニルアラニン化合物の塩の回収方法、およびそれを用いたビフェニルアラニンエステル化合物の回収方法
CN106946724B (zh) * 2017-04-07 2019-03-22 苏州汉德创宏生化科技有限公司 单胺基抑制剂类中间体2-乙酰氨基-2-苄基丙二酸单乙酯的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981799A (en) * 1987-08-21 1991-01-01 Takeda Chemical Industries, Ltd. Acylamino acid racemase, production and use thereof
DE4115468A1 (de) * 1991-05-11 1992-11-12 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien
AU662522B2 (en) * 1991-05-13 1995-09-07 Fujisawa Pharmaceutical Co., Ltd. New peptide compound and a process for the preparation thereof
SK286094B6 (sk) * 1994-04-26 2008-03-05 Aventis Pharmaceuticals Inc. Zlúčenina špecificky inhibujúca aktivitu faktora Xa, farmaceutická kompozícia s jej obsahom a jej použitie

Also Published As

Publication number Publication date
NO319678B1 (no) 2005-09-05
WO1997022712A1 (en) 1997-06-26
BR9612059A (pt) 1999-02-23
TR199801107T2 (xx) 1998-10-21
PL185541B1 (pl) 2003-05-30
CN1087349C (zh) 2002-07-10
JP2000501618A (ja) 2000-02-15
EP0868526A1 (en) 1998-10-07
EE03698B1 (et) 2002-04-15
SK85598A3 (en) 1998-12-02
NO982868D0 (no) 1998-06-19
DK0868526T3 (da) 2002-12-02
AU717995B2 (en) 2000-04-06
ES2179957T3 (es) 2003-02-01
CZ195698A3 (cs) 1999-01-13
RU2170764C2 (ru) 2001-07-20
UA48993C2 (uk) 2002-09-16
NO982868L (no) 1998-08-19
PT868526E (pt) 2002-12-31
JP4044614B2 (ja) 2008-02-06
CZ295362B6 (cs) 2005-07-13
IL125003A (en) 2001-12-23
IL125003A0 (en) 1999-01-26
AR005119A1 (es) 1999-04-14
KR100438879B1 (ko) 2004-07-16
DE69623038T2 (de) 2002-12-12
EE9800188A (et) 1998-12-15
KR20000064486A (ko) 2000-11-06
CA2241210C (en) 2002-05-14
CN1205742A (zh) 1999-01-20
PL327314A1 (en) 1998-12-07
ZA9610600B (en) 1997-06-20
HK1017384A1 (en) 1999-11-19
DE69623038D1 (de) 2002-09-19
MX9804997A (es) 1998-09-30
AU1125197A (en) 1997-07-14
ATE222293T1 (de) 2002-08-15
EP0868526B1 (en) 2002-08-14
NZ324159A (en) 1999-07-29
CA2241210A1 (en) 1997-06-26

Similar Documents

Publication Publication Date Title
JP2945680B2 (ja) ペプチド誘導体およびその用途
US4316889A (en) Novel peptidyl-arginine aldehyde derivatives and process for the preparation thereof
RU2088591C1 (ru) Производные амидинофенилаланина, способ их получения и производные амидинофенилаланина, обладающие антикоагулирующей активностью
US5932733A (en) 3-amino-2-oxo-1-piperidineacetic derivatives containing an arginine mimic as enzyme inhibitors
KR100339456B1 (ko) 신규펩티드유도체
US6034067A (en) Serine protease inhibitors
EP0699074A1 (en) Thrombin inhibitors
US6410684B1 (en) Serine protease inhibitors
AU4111700A (en) Low-molecular inhibitors of complement proteases
CS106492A3 (en) Derivatives of amidinophenylalanine, process for preparing thereof, theiruse and compositions comprising said derivatives
SK281432B6 (sk) Spôsob prípravy n-acetyl-(l)-4-kyanofenylalanínu ac-(l)-phe(4- -cn)-oh a n-acetyl-(l)-p-amidinofenylalanín-cyklohexylglycín- -beta-(3-n-metylpyridínium)-alanínu ac-(l)-paph-chg-palme(3)-nh2
EP0313969B1 (en) Tripeptide derivatives and antiplasmin agents containing the same
EP0817795B1 (en) Novel 4-substituted-3-peptidyl-azetidin-2-one derivatives useful as cysteine proteinase inhibitor
US5686419A (en) Basic α-aminoalkylphosphonate derivatives
US5952307A (en) Basic α-aminoalkylphosphonate derivatives
EP0956293B1 (en) Thrombin inhibitors
CA2384247A1 (en) Azacycloalkanone serine protease inhibitors
US5766932A (en) Process for preparing N-acetyl(L)-4-cyanophenylalanine from a mixture of the corresponding D,L ethyl esters using subtilisin
TW389755B (en) Novel process for preparing n-acetyl (1) -4-cyanophenylalanine ac -(1) -phe (4-cn) -oh and n-acetyl -(1)-p-amidinophenylalanine-cyclohexylglycine-<beta>-(3-n-methylpyridinium)-alanine ac-(1)-paph-chg-palme(3)-nh2
US5948939A (en) Selective amidination of diamines
Bizzozero et al. Enzyme‐Catalyzed Peptide‐Bond Formation: Elastase‐and δ‐Chymotrypsin‐Assisted Synthesis of Oligopeptides
JPH0778038B2 (ja) Ｌ―アルギニナールジ低級アルキルアセタールの製造法

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20111125